Conmed Q3 2024 Adj. EPS $1.05 Beats $0.99 Estimate, Sales $316.701M Miss $318.128M Estimate
CONMED Corporation +0.07% Pre
CONMED Corporation CNMD | 74.74 74.74 | +0.07% 0.00% Pre |
Conmed (NYSE:
CNMD) reported quarterly earnings of $1.05 per share which beat the analyst consensus estimate of $0.99 by 6.06 percent. The company reported quarterly sales of $316.701 million which missed the analyst consensus estimate of $318.128 million by 0.45 percent. This is a 3.98 percent increase over sales of $304.578 million the same period last year.
